The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES) : Final 24-Month Patient-Reported Outcomes

被引：0
|
作者：
Fuechtenbusch, Martin
Guerci, Bruno
Giorgino, Francesco
Garcia-Perez, Luis-Emilio
Heitmann, Elke
Lebrec, Jeremie
Barrett, Annabel
Dib, Anne
Federici, Marco Orsini
Boye, Kristina
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-738-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
738-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Final patient-reported outcomes at 24 months
    Boye, Kristina S.
    Lebrec, Jeremie
    Dib, Anne
    Heitmann, Elke
    Federici, Marco Orsini
    Yu, Maria
    Sapin, Helene
    Barrett, Annabel
    Guerci, Bruno
    Giorgino, Francesco
    Fuechtenbusch, Martin
    Garcia-Perez, Luis-Emilio
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3453 - 3464
  • [2] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes
    Boye, Kristina S.
    Sapin, Helene
    Garcia-Perez, Luis-Emilio
    Rosilio, Myriam
    Orsini Federici, Marco
    Heitmann, Elke
    Jung, Heike
    Aigner, Ulrich
    Guerci, Bruno
    Giorgino, Francesco
    Norrbacka, Kirsi
    [J]. DIABETES THERAPY, 2020, 11 (10) : 2383 - 2399
  • [3] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE AND LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): PATIENT-REPORTED OUTCOMES AT BASELINE
    Boye, K.
    Garcia-Perez, L. E.
    Sapin, H.
    Rosilio, M.
    Federici, Orsini M.
    Heitmann, E.
    Jung, H.
    Gentilella, R.
    Aigner, U.
    Guerci, B.
    Giorgino, F.
    Norrbacka, K.
    [J]. VALUE IN HEALTH, 2019, 22 : S593 - S593
  • [4] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes
    Kristina S. Boye
    Hélène Sapin
    Luis-Emilio García-Pérez
    Myriam Rosilio
    Marco Orsini Federici
    Elke Heitmann
    Heike Jung
    Ulrich Aigner
    Bruno Guerci
    Francesco Giorgino
    Kirsi Norrbacka
    [J]. Diabetes Therapy, 2020, 11 : 2383 - 2399
  • [5] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES) : Final 24-Month Primary Endpoint Analysis
    Giorgino, Francesco
    Guerci, Bruno
    Garcia-Perez, Luis-Emilio
    Fuechtenbusch, Martin
    Lebrec, Jeremie
    Federici, Marco Orsini
    Dib, Anne
    Heitmann, Elke
    Yu, Maria
    Boye, Kristina
    [J]. DIABETES, 2022, 71
  • [6] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES) : Final 24-Month Clinical Characteristics and Treatment Pattern Analyses
    Guerci, Bruno
    Giorgino, Francesco
    Boye, Kristina
    Fuechtenbusch, Martin
    Heitmann, Elke
    Lebrec, Jeremie
    Dib, Anne
    Federici, Marco Orsini
    Yu, Maria
    Garcia-Perez, Luis-Emilio
    [J]. DIABETES, 2022, 71
  • [7] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE & LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): PATIENT REPORTED OUTCOMES AT 12-MONTHS
    Boye, K.
    Lebrec, J.
    Sapin, H.
    Guerci, B.
    Giorgino, F.
    Fuechtenbusch, M.
    Heitmann, E.
    Federici, Orsini M.
    Dib, A.
    Garcia-Perez, L. E.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S242 - S242
  • [8] The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (TROPHIES): Final, 24-month analysis of time to first significant treatment change, treatment persistence and clinical outcomes
    Giorgino, Francesco
    Guerci, Bruno
    Fuechtenbusch, Martin
    Lebrec, Jeremie
    Boye, Kristina
    Federici, Marco Orsini
    Heitmann, Elke
    Dib, Anne
    Yu, Maria
    Sapin, Helene
    Garcia-Perez, Luis-Emilio
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3465 - 3477
  • [9] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Twelve-Month Data Analysis
    Guerci, Bruno
    Giorgino, Francesco
    Garcia, Luis-Emilio
    Boye, Kristina
    Norrbacka, Kirsi
    Sapin, Helene
    Heitmann, Elke
    Lebrec, Jeremie
    Dib, Anne
    Federici, Marco O. Orsini
    [J]. DIABETES, 2021, 70
  • [10] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE & LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): 6-MONTH ANALYSIS RESULTS
    Giorgino, F.
    Guerci, B.
    Garcia-Perez, L. E.
    Boye, K.
    Aigner, U.
    Heitmann, E.
    Federici, Orsini M.
    Zimner-Rapuch, S.
    Rosilio, M.
    Norrbacka, K.
    Sapin, H.
    [J]. VALUE IN HEALTH, 2020, 23 : S506 - S506
12345